The pharmaceutical industry is rapidly evolving, with growing demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To meet this demand, US-based manufacturing services are emerging. These companies offer a comprehensive suite of capabilities, from research and deve